ACSL4 and pancreatic ductal adenocarcinoma: The knockdown of PIR increased mRNA levels of ACSL4, a biomarker and a key promoter of ferroptosis, in pancreatic ductal adenocarcinoma cell lines (Hu et al., 2021).